Aurora Cannabis announced today that the company has signed a binding share purchase agreement whereby Aurora has acquired all of the issued and outstanding common shares of privately-held Chemi Pharmaceutical, an Ontario -based laboratory specialized in providing high quality analytics services to the pharmaceutical and cannabis industries, in a cash and share transaction.
Featured News
California AG Says No Paramount Settlement Talks Scheduled
Aug 25, 2026 by
CPI
Judge Lets Antitrust Case Against 32 US Universities Move Forward
Aug 25, 2026 by
CPI
CoStar Hit With Consolidated Antitrust Challenge Over Property Data
Aug 25, 2026 by
CPI
Express Scripts Wins Dismissal of Nonprofit Pharmacy’s Antitrust Claims
Aug 25, 2026 by
CPI
Draghi, Business Leaders Form Group Focused on European Competitiveness
Aug 25, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Antipasto
Aug 24, 2026 by
CPI
“Anti-Monopoly” Antitrust Enforcement: Lessons Learned from the Biden Administration
Aug 24, 2026 by
Diana L. Moss
FTC v. Meta: The Importance of Quantitative Evidence in Antitrust
Aug 24, 2026 by
Dennis Carlton, John A. List, Allan Shampine, Hal Sider & Theresa Sullivan
Competitor Information Exchanges: Reducing Market Uncertainty Is What Matters, Not Level Of Detail
Aug 24, 2026 by
Kasia Czapracka, Assimakis Komninos, James Killick & Nina Frie
When Politics Meets Merger Control: 10 Transatlantic Takeaways
Aug 24, 2026 by
Rachel Brandenburger